Overview
The Rheumatology Winter Clinical Symposium (RWCS) is one of the most respected and dynamic continuing medical education events in the field of rheumatology. Now celebrating its 20th annual meeting, this premier gathering brings together leading rheumatologists, immunologists, and specialist clinicians from across the country and around the world to share the latest advances, controversies, and clinical insights shaping the future of rheumatologic care.
Held annually at the Wailea Marriott in Maui, Hawaii, RWCS is designed to provide attendees with an intensive yet collegial educational experience. Over four days, participants engage with a rich program of expert-led sessions, interactive workshops, case-based discussions, and industry-sponsored events—all within a setting that encourages open dialogue and professional collaboration.
For two decades, RWCS has served as a trusted venue for rheumatology professionals to stay current with rapidly evolving treatment paradigms, emerging therapies, and evidence-based clinical practice guidelines. The symposium’s distinctive combination of formal presentations, expert Q&A sessions, and small-group discussions has made it an annual highlight for practitioners seeking both scientific rigor and practical clinical applicability.
Target Audience
This educational activity is directed toward rheumatologists, nurse practitioners, physician associates, and other members of the care team involved in diagnosing and treating patients with rheumatic disorders.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Differentiate the immunopathogenesis of the major autoimmune, systemic inflammatory rheumatic diseases
- Assess the mechanisms of action of various agents used in the treatment of rheumatic diseases
- Analyze clinical trial efficacy and safety data for novel and emerging therapies for the treatment of rheumatic diseases
- Develop patient-centered treatment approaches for patients with rheumatic diseases
- Implement supportive care strategies for addressing any treatment-related adverse events in patients receiving novel therapies